The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors

Prevalence of Antitumor Antibodies in Laying Hen Model of Human Ovarian Cancer

(2010) Animesh Barua et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Histopathology of Ovarian Tumors in Laying Hens

(2010) Animesh Barua et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer

(2009) Kristine Ansenberger et al.   GYNECOLOGIC ONCOLOGY

Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients

(2008) I. Hellstrom et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

High Shed Antigen Levels within Tumors: An Additional Barrier to Immunoconjugate Therapy

(2008) Y. Zhang et al.   CLINICAL CANCER RESEARCH

VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer

(2008) M.E. Urick et al.   GYNECOLOGIC ONCOLOGY

Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer

(2008) Karen Stammer et al.   GYNECOLOGIC ONCOLOGY

Dietary aspirin decreases the stage of ovarian cancer in the hen

(2008) M.E. Urick et al.   GYNECOLOGIC ONCOLOGY

CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus

(2008) Yan Zhuge et al.   GYNECOLOGIC ONCOLOGY

Mesothelin targeted cancer immunotherapy

(2007) Raffit Hassan et al.   EUROPEAN JOURNAL OF CANCER